Editas Medicine (EDIT) Change in Acquisitions & Divestments (2017 - 2025)

Editas Medicine (EDIT) has reported Change in Acquisitions & Divestments for 9 consecutive years, with $40.0 million the latest figure, recorded in Q3 2025.

• In Q3 2025, Change in Acquisitions & Divestments fell 53.96% year-over-year to $40.0 million; the TTM figure through Sep 2025 stood at $170.5 million (down 48.11% YoY), while the FY2024 annual figure was $257.2 million, down 0.89% from the prior year.
• Change in Acquisitions & Divestments eased to $40.0 million in Q3 2025 per EDIT's latest filing, from $42.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $130.8 million in Q1 2021 and bottomed at $31.5 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $76.4 million across 5 years, with a median of $74.2 million in 2021.
• Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments surged 176.48% — and 2024, when it sank 69.39%.
• Editas Medicine's Change in Acquisitions & Divestments stood at $84.3 million in 2021, then slipped by 6.91% to $78.5 million in 2022, then surged by 31.08% to $102.9 million in 2023, then tumbled by 69.39% to $31.5 million in 2024, then advanced by 27.03% to $40.0 million in 2025.
• Business Quant data shows EDIT's Change in Acquisitions & Divestments at $40.0 million in Q3 2025, $42.5 million in Q2 2025, and $56.5 million in Q1 2025.